We are live on ! Find out more
N

Nuveen Portfolio holdings

AUM $369B
1-Year Est. Return 31.66%
This Fund
S&P 500
This Quarter Est. Return
+9.39%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$335B
AUM Growth
+$21B
Cap. Flow
-$4B
Cap. Flow %
-1.19%
Top 10 Hldgs %
21.52%
Holding
3,670
New
323
Increased
1,420
Reduced
1,524
Closed
323

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$1.66B
2
BABA icon
Alibaba
BABA
+$881M
3
INTC icon
Intel
INTC
+$783M
4
GOOG icon
Alphabet (Google) Class C
GOOG
+$783M
5
LIN icon
Linde
LIN
+$667M

Sector Composition

Rank Sector Weight
1 Technology 23.8%
2 Financials 13%
3 Consumer Discretionary 12.7%
4 Healthcare 12.61%
5 Communication Services 10.18%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CAI
2376
DELISTED
CAI International, Inc.
CAI
$3.73M ﹤0.01%
66,506
-7,204
-10% -$320K
MTW icon
2377
Manitowoc
MTW
$675M
$3.72M ﹤0.01%
151,883
-6,178
-4% -$147K
ACCO icon
2378
Acco Brands
ACCO
$407M
$3.71M ﹤0.01%
429,811
-9,941
-2% -$88.4K
PLAB icon
2379
Photronics
PLAB
$1.93B
$3.7M ﹤0.01%
280,341
-21,143
-7% -$277K
HCC icon
2380
Warrior Met Coal
HCC
$4.86B
$3.7M ﹤0.01%
215,249
-4,053
-2% -$70.7K
OCUL icon
2381
Ocular Therapeutix
OCUL
$2.02B
$3.7M ﹤0.01%
260,708
+5,757
+2% +$87.5K
GRTS
2382
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
$3.68M ﹤0.01%
402,796
+269,270
+202% +$2.49M
CIO
2383
DELISTED
City Office REIT
CIO
$3.65M ﹤0.01%
293,979
+35,733
+14% +$414K
ASXC
2384
DELISTED
Asensus Surgical, Inc.
ASXC
$3.64M ﹤0.01%
+1,148,754
New +$2.87M
ATNX
2385
DELISTED
Athenex, Inc. Common Stock
ATNX
$3.64M ﹤0.01%
15,030
-9,820
-40% -$893K
CARM
2386
DELISTED
Carisma Therapeutics
CARM
$3.63M ﹤0.01%
+39,340
New +$2.51M
PCVX icon
2387
Vaxcyte
PCVX
$8.64B
$3.62M ﹤0.01%
160,836
+65,143
+68% +$1.33M
RUBY
2388
DELISTED
Rubius Therapeutics, Inc
RUBY
$3.61M ﹤0.01%
147,792
-11,701
-7% -$293K
WMK icon
2389
Weis Markets
WMK
$1.86B
$3.6M ﹤0.01%
69,729
+25,657
+58% +$1.36M
OZON
2390
DELISTED
Ozon Holdings PLC American Depositary Shares, each ADS representing one ordinary share
OZON
$3.59M ﹤0.01%
+61,280
New +$3.57M
NAGE
2391
Niagen Bioscience
NAGE
$247M
$3.59M ﹤0.01%
363,919
+207,036
+132% +$1.81M
HCM icon
2392
HUTCHMED
HCM
$2.17B
$3.59M ﹤0.01%
91,347
+19,421
+27% +$561K
HEES
2393
DELISTED
H&E Equipment Services
HEES
$3.58M ﹤0.01%
107,632
-42,968
-29% -$1.57M
OIBR.C
2394
DELISTED
OI S.A. American Depositary Shares, each representing five shares of common stock
OIBR.C
$3.58M ﹤0.01%
2,403,209
ENTA icon
2395
Enanta Pharmaceuticals
ENTA
$400M
$3.57M ﹤0.01%
81,156
-3,863
-5% -$189K
PRTY
2396
DELISTED
Party City Holdco Inc.
PRTY
$3.57M ﹤0.01%
+382,831
New +$3.12M
WNC icon
2397
Wabash National
WNC
$527M
$3.56M ﹤0.01%
222,680
-35,994
-14% -$618K
BNFT
2398
DELISTED
Benefitfocus, Inc.
BNFT
$3.56M ﹤0.01%
252,566
-7,606
-3% -$107K
AGEN
2399
Agenus
AGEN
$290M
$3.54M ﹤0.01%
32,894
-13,042
-28% -$978K
CERT icon
2400
Certara
CERT
$1.25B
$3.54M ﹤0.01%
124,844
-3,522
-3% -$97.8K

Similar funds

Nuveen's Q2 2021 Portfolio in Review

As of Q2 2021, Nuveen held 3,670 positions worth $335B, up 6.7% from $314B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Nuveen's Q2 2021 filing shows 323 new, 1,420 increased, 1,524 reduced and 323 closed positions. Its largest new stake was UiPath: 2,457,331 shares worth $167M. The largest sale was Apple, an estimated $1.66B.

By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 23% a quarter earlier, followed by Financials and Consumer Discretionary.

  • Nuveen's largest Q2 2021 buy was UiPath: 2,457,331 shares worth $167M.
  • Nuveen added most to Wells Fargo in Q2 2021, an estimated $512M increase.
  • Nuveen's biggest Q2 2021 reduction was Apple, cutting an estimated $1.66B.
  • Nuveen fully exited SolarEdge in Q2 2021, selling an estimated $66M.
  • Nuveen's ten largest holdings make up 22% of its $335B portfolio in Q2 2021.
  • Nuveen opened 323 new positions and closed 323 in Q2 2021.
  • Nuveen's portfolio value rose 6.7% quarter-over-quarter to $335B.

Based on Nuveen's 13F filing for Q2 2021, filed 16 Aug 2021.